IP & Life Science News

Stay updated on the latest news on IP and life science.
Contributors are the IP and Life Science experts from Accura Law Firm.

”Very good legal and industry knowledge. Focuses on the relevant items”
”Great team of engaging and hard-working lawyers.”
“Always pragmatic, commercial yet diligent and fun to work with.”
“Highly recommendable.”
Legal 500

Open IP and Life Science News – volume 29 – June 2022:

In this edition we are looking into whether preliminary injunctions can be based on a patent pre-grant – a question that has recently been tried before several courts around Europe, including in Denmark and the UK. Further, we prove a reminder on the benefits of registering trademarks and an overview of the recently amended Codes and Guidelines from ENLI. Contributors to this edition are Morten Bruus, Christina Type Jardorf, Christoffer Ege Andersen, Amalie Rosenbaum Petersen, Daniel Mathias Bager, Rebecca Hvidt and Christian Jul Gjølbo.

  • Can a preliminary injunction be based on a patent pre-grant?
  • New case law on the importance of registering trademarks
  • Revision of ENLI’s Codes and Guidelines
  • New partner to strengthen Accura’s IP & Life Science team

Open IP and Life Science News – volume 28 – May 2022:

With a focus on new legislation within IP and Life Sciences, we present articles on the new transparency requirements for online marketing in the Danish Marketing Practices Act that enter into force later this week, the EU Commission’s proposal for a European Health Data Space and upcoming directive amendments to fight green washing. We also bring on some good news for design companies with a short update on China’s entering into the Hague System. Contributors are Christina Type Jardorf, Christoffer Ege Andersen, Amalie Rosenbaum Petersen, Daniel Mathias Bager, Christian Jul Gjølbo and Caroline Dybbro Andersen.

  • New transparency requirements for online marketing
  • Proposal for a European Health Data Space Regulation
  • EU Commission proposes directive amendments to fight greenwashing
  • Design protection in China just got easier

Open IP and Life Science News – volume 27 – April 2022:

Read about a recent court decision that puts into question the existence of a non-statutory caricature exception in Danish copyright law, the newly launched Design Tribunal, Russia’s attempt to nationalise foreign IP rights and about DKTPO providing partial refunds for patent application fees for SMEs. Contributors are Christina Type Jardorf, Christoffer Ege Andersen, Amalie Rosenbaum Petersen, Daniel Mathias Bager, Christian Jul Gjølbo and Caroline Dybbro Andersen.

  • Is free speech just a fairy tale in Danish copyright law?
  • New Danish Design Tribunal: Disputes on architecture, design and handicraft can now be filed
  • Russia to nationalise foreign intellectual property rights?
  • Calling on Danish SMEs: Partial refunds for patent application expenses available at DKPTO

Open IP and Life Science News – volume 26 – February 2022:

Read about NFTs and metaverses, an upcoming split-up of the executive order and guidance on advertising for medicinal products for human beings and animals and the EU SME Fund offering partial refunds of IP registration fees throughout 2022. Contributors are Christina Type Jardorf, Christoffer Ege Andersen, Amalie Rosenbaum Petersen, Christian Jul Gjølbo and Caroline Dybbro Andersen.

  • NFTs and the metaverse: A new era in the digital age – and in the exploitation of IP-rights
  • Changes to the rules on advertising for medicinal products for human beings and animals
  • Did you know?: EU SME Fund offers partial refunds of IP registration fees

Open IP and Life Science News – volume 25 – January 2022:

Read about a new and important decision from ENLI’s Appeals Board on the Lobbying Code, the introduction of conditional recommendations of medicinal products at the Danish Medicinal Council and on trends of 2022 on digital IP infringements and how to avoid the. Contributors are Morten Bruus, Christina Type Jardorf, Christoffer Ege Andersen, Sarah Veje Rasmussen, Amalie Rosenbaum Petersen and Christian Jul Gjølbo.

  • New important decision from ENLI’s Appeal Board; On the ethical rules for the pharmaceutical industry’s dialogue and negotiations with decision-makers (the Lobbying Code)
  • 2022-trends: Digital IP infringements and how to avoid them
  • New practice at The Danish Medicines Council: Conditional recommendations of medicinal products

Open IP and Life Science News – volume 24 – May 2021:

On the new Danish Health Technology Council, Parliament’s extension of the Danish pilot programme on medicinal cannabis and how to preserve evidence when suspecting an IP infringement. Contributors are Christoffer Ege Andersen, Christina Type Jardorf, Amalie Rosenbaum Petersen, Rebecca Hvidt and Maria Sudergaard Larsen.

  • New Danish Health Technology Council to recommend health technologies – Get the full overview
  • Internal preservation of evidence – A key initial step when suspecting IP infringements
  • Extension of the Pilot Programme on Medicinal Cannabis

Open IP and Life Science News – volume 23 – April 2021:

On the Medicines Agency’s now permanent powers in light of COVID-19, bad faith trademark applications, geographical indications and new recommendations for medicinal cannabis companies. Contributors are Morten Bruus, Christina Type Jardorf, Amalie Rosenbaum Petersen, Martin Dysterdich Jørgensen and Rebecca Hvidt Hein.

  • The Danish Medicines Agency’s powers to prevent supply shortage in light of COVID-19 are now permanent
  • The commercial reason for bad faith as a ground for trademark invalidation
  • New recommendations to assist medicinal cannabis companies in complying with security requirements
  • The geography of geographical indications

Open IP and Life Science News – volume 22 – February 2021:

On the Medicines Council’s new principles for the use of unpublished data an on the the up-and-coming implementation of the DSM-Directive to enhance liability for tech companies. Contributors are Morten Bruus, Christoffer Ege Andersen, Melissa Tronier Kapper and Amalie Rosenbaum Petersen.

  • The Danish Medicines Council issues new principles for use of unpublished data
  • Amendments to the Danish Copyright Act on the way: Enhanced liability for tech companies

Open IP and Life Science News – volume 21 – December 2020:

Latest news on IPR and Life Science from Accura. Contributors are Morten Bruus, Tobias Triton Frost and Amalie Rosenbaum Petersen.

  • Danish court issues important ruling in pharma press release case between Sanofi and Novo Nordisk
  • EU directs action plan and strategy to IP and life science
  • Higher legal costs awarded in IP litigation in Denmark

Open IP and Life Science News – volume 20 – November 2020:

  • A new design tribunal emerges in Denmark
  • Food for Thought for Food Influencers and Companies
  • How to use Google Ads correctly and avoid lawsuits from your competitors

Open IP and Life Science News – volume 19 – June 2020:

  • Does copyright provide sufficient protection when it rains in Denmark?
  • Increase in tax allowance for R&D further secures Denmark’s status as R&D hotspot
  • Trademark protection in China – in Chinese or Latin?

Open IP and Life Science News – Volume 18 – May 2020:

  • How to conduct Clinical Trials during the COVID-19 pandemic
  • The advocate general challenges recent CJEU case law on SPCs for second medical use
  • Danish High Court dismisses illegal downloading and file sharing cases

Open IP and Life Science News – Volume 17 – March 2020:

  • Danish Court changes course and acquits the defendant for illegal downloading and file sharing
  • Use of “linkbuilding” and rules on hidden advertisement
  • Unpublished data and the Danish Medicines Council